Clinical data | |
---|---|
Other names | SC-26304; 7α-Carboxyisopropylspirolactone; 17α-Hydroxy-3-oxopregn-4-ene-7α,21-dicarboxylic acid γ-lactone 1-isopropyl ester |
Routes of administration | Oral |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H36O5 |
Molar mass | 428.569 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Dicirenone (INN, USAN; developmental code name SC-26304; also known as 7α-carboxyisopropylspirolactone) is a synthetic, steroidal antimineralocorticoid of the spirolactone group which was developed as a diuretic and antihypertensive agent but was never marketed. It was synthesized and assayed in 1974. Similarly to other spirolactones like spironolactone, dicirenone also possesses antiandrogen activity, albeit with relatively reduced affinity.
Mineralocorticoid receptor modulators | |||||
---|---|---|---|---|---|
MRTooltip Mineralocorticoid receptor |
| ||||
See also Receptor/signaling modulators Mineralocorticoids and antimineralocorticoids Glucocorticoid receptor modulators List of corticosteroids |
This article about a steroid is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |